Frontlight ResearchEarly access
Childhood cancers trials in France
207 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Amiens Cedex 1, Angers, Besançon, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, Grenoble Cedex 9, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 5, Nice, Paris, Poitiers, Reims Cedex, Rennes, Rouen Cedex, Saint-Denis, Saint-Etienne, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy, Villejuif
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - No phaseTaking peopleFunctional and Aesthetic Outcomes Following Lower Lip Reconstruction
- Where
- Cergy-Pontoise
- People
- 20
- Run by
- Hôpital NOVO
See details and how to joinNCT07298070 - No phaseTaking peopleCANUT Junior : Assessment of Sensory Abilities and Eating Behavior in Pediatric Oncology: a Feasibility Study
- Where
- Lyon
- Age
- 7 years to 17 years
- People
- 30
- Run by
- Centre Leon Berard
See details and how to joinNCT07632560 - No phaseTaking peopleVirtual Reality for Children in Radiotherapy (REVER)
- Where
- Nice
- Age
- 7 years to 18 years
- People
- 47
- Run by
- Centre Antoine Lacassagne
See details and how to joinNCT04934293 - Phase 1/2Active, not recruitingA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Dijon, Grenoble Cedex 9, Nice Cedex 2, Villejuif
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleFrench National Database of Rare Dermatological Cancers
- Where
- Amiens, Angers, Annecy, Besançon, Bobigny, Boulogne-Billancourt, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Le Mans, Limoges, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Orléans, Paris, Pessac, Pierre-Bénite, Pointe à Pitre, Poitiers, Reims, Rennes, Rouen, Strasbourg, Toulouse, Tours, Villejuif
- People
- 9,000
- Run by
- University Hospital, Lille
See details and how to joinNCT03210935 - No phaseTaking peopleA Clinico-biological Database of Lung Cancers
- Where
- Lille
- People
- 500
- Run by
- University Hospital, Lille
See details and how to joinNCT03387865 - No phaseNot yet taking people in FranceClinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease
- Where
- Saint-Herblain
- Age
- Up to 45 years
- People
- 1,000
- Run by
- Institut Cancerologie de l'Ouest
See details and how to joinNCT07601152 - Phase 3Taking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Amiens Cedex 1, Angers, Besançon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, La Tronche, Lille Cedex, Limoges, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Reims Cedex, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
- Age
- Up to 64 years
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 - No phaseTaking peopleEvaluation of the Effect of a Physical Activity Recovery Stay
- Where
- Nancy
- Age
- 8 years to 18 years
- People
- 50
- Run by
- Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
See details and how to joinNCT06320496 - Phase 1/2Taking peopleA phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
- Where
- Bordeaux, Lille, Paris, Toulouse, Vandoeuvre Les Nancy
- Age
- Up to 64 years
- People
- 72 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 - Phase 3Not yet taking people in FranceInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Denis, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - Phase 1Taking peopleSafety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
- Where
- Paris, Villejuif
- Age
- 5 years to 17 years
- People
- 24
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05293197 · EU 2024-516169-35-00 - Phase 2Taking peopleSafety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
- Where
- Paris, Villejuif
- Age
- 6 months to 17 years
- People
- 31 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508931 · EU 2023-506348-17-00 - Phase 2Not yet taking people in FranceTovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
- Where
- Paris
- Age
- 1 year to 39 years
- People
- 57 worldwide
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT05465174 · EU 2024-511510-20-00 - No phaseTaking peopleImpact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With Cancer
- Where
- Lyon
- Age
- 15 years to 25 years
- People
- 214
- Run by
- Centre Leon Berard
See details and how to joinNCT05858424 - No phaseTaking peopleRATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
- Where
- Marseille, Rouen
- People
- 100 worldwide
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07541521 - No phaseTaking peopleStudy to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer
- Where
- Toulouse
- Age
- 18 months and over
- People
- 200
- Run by
- Institut Claudius Regaud
See details and how to joinNCT04740697 - No phaseTaking peopleDownstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
- Where
- Marseille, Rouen
- People
- 200 worldwide
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07528066 - No phaseNot yet taking people in FranceRole of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
- Where
- Marseille, Nice
- Age
- 1 year to 99 years
- People
- 20
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07529223 - No phaseNot yet taking people in FranceEvaluation of the Effects of Equicoaching on Social Reintegration Among Young Adults Who Have Been Treated for Cancer
- Where
- Lyon
- Age
- 15 years to 25 years
- People
- 10
- Run by
- Centre Leon Berard
See details and how to joinNCT07515274 - No phaseTaking peopleBrain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years
- Where
- Angers, Bron, Rennes
- Age
- 4 years to 18 years
- People
- 230
- Run by
- University Hospital, Angers
See details and how to joinNCT06618703 - Phase 2/3Not yet taking people in FranceA Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Where
- Lyon, Paris
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00 - No phaseTaking peopleSecuring Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
- Where
- Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille, Montpellier, Nancy, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Denis, Saint-Etienne, Strasbourg, Toulouse, Tours, Villejuif
- Age
- Up to 25 years
- People
- 1,150
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04477681 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Talence, Villejuif
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555